Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 9:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 18,261 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Prescription Drug Abuse
Interventions: MyHealthyChoices, Health Risk Assessment; Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Morgantown, West Virginia

Conditions: Small Cell Lung Cancer
Interventions: Pembrolizumab 200 mg, Pembrolizumab 400 mg, Pembrolizumab placebo (saline), Olaparib 300 mg BID, Olaparib matching placebo, Etoposide 100 mg/m^2, Platinum, investigator's choice, Standard Thoracic Radiotherapy, Prophylactic Cranial Irradiation (PCI); Biological · Drug · Radiation
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 672 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 35
States / cities: Chandler, Arizona • Loma Linda, California • Washington D.C., District of Columbia + 29 more

Conditions: Atopic Dermatitis
Interventions: Montelukast, Placebo; Drug
Lead sponsor: 1st Allergy & Clinical Research Center; Other
Eligibility: 1 Year to 8 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Centennial, Colorado • Thornton, Colorado

Conditions: Type 2 Diabetes Mellitus
Interventions: WellStart; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Injuries
Interventions: A pre-dive checklist; Other
Lead sponsor: Divers Alert Network; Network
Eligibility: 18 Years and older
Enrollment: 1,116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Diabetic Foot Osteomyelitis
Interventions: STIMULAN VG, Systemic Antibiotics; Drug
Lead sponsor: Biocomposites Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 10
States / cities: Mesa, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 6 more

Conditions: Overweight and Obesity
Interventions: ER, SBWC; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Gastrointestinal Disease Symptoms
Interventions: Prebiotic, probiotic, postbiotic combination, Placebo; Dietary Supplement
Lead sponsor: Colorado State University; Other
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Depressive Symptoms, Anxiety Generalized
Interventions: Mobile Phone Application; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 17 Years to 20 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, Cryptococcosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1993
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypercholesterolaemia
Interventions: Alirocumab SAR236553, Current auto-injector device (AI), New auto-injector device (SYDNEY), Atorvastatin, Rosuvastatin; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 13
States / cities: Los Angeles, California • Jacksonville, Florida • Ponte Vedra, Florida + 8 more

Conditions: HIV, Risk Reduction Behavior
Interventions: MILE intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Male only
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Health Knowledge, Attitudes, Practice
Interventions: Online educational phthalate course, Control environmental education, Phthalate conversation, Environmental exposures conversation; Behavioral
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Health Knowledge, Attitudes, Practice
Interventions: Nutrition Literacy Assessment Instrument (NLit); Diagnostic Test
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 5
States / cities: Kansas City, Kansas • Overland Park, Kansas • Kansas City, Missouri

Conditions: Obesity
Interventions: Behavioral Weight Loss, Enhanced Behavioral Weight Loss; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Kidney Disease, Uncontrolled Hypertension
Interventions: Telehealth; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain, Postoperative, Root Canal Infection, Endodontically Treated Teeth
Interventions: GentleWave, Conventional Protocol; Other
Lead sponsor: University of Salamanca; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Manhattan, New York

Conditions: Asthma
Interventions: Fluticasone propionate/Formoterol fumarate 250/10, Placebo, Fluticasone propionate/Formoterol fumarate 100/10, Fluticasone propionate 250, Formoterol fumarate 10; Drug
Lead sponsor: SkyePharma AG; Industry
Eligibility: 12 Years and older
Enrollment: 557 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 62
States / cities: Pell City, Alabama • Glendale, Arizona • Phoenix, Arizona + 53 more

Conditions: Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children, Hyperlipidemia in Children
Interventions: Best Practice Alert, Health Maintenance Topic; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 9 Years to 11 Years
Enrollment: 13,340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Parkinson's Disease
Interventions: gait and balance training program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Medication Compliance, Pain
Interventions: HOPE Intervention; Behavioral
Lead sponsor: ElevateU; Industry
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Corona del Mar, California

Conditions: NASH
Interventions: EDP 305; Drug
Lead sponsor: Enanta Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hematologic Malignancy, Blood Cancer, Lymphoma, Leukemia, Multiple Myeloma
Interventions: Palliative Care, Usual Care; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain
Interventions: Chronic Disease Self-Management Program (CDSMP) for chronic pain in Spanish, Remote feedback active group, Remote feedback control group; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 40 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens

WellStart Reboot Study

Common Recreational Diving Practices: A Randomized Control Trial Using Pre-Dive Checklist

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

Improving Emotion Regulation Skills Among Adolescents Attempting to Lose Weight

Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women

Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men

Fungal Infection Susceptibility

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

The HJ MILE HIV Prevention Intervention for Post-incarcerated Men

Doulas as Environmental Educators and Partners Study

Measuring Nutrition Literacy in Clinical Practice: Evaluating Effects Upon Providers and Patients

A Weight Loss Trial for Emotional Eating

Integrated Population Program for Diabetic Kidney Disease

Effectiveness of GentleWave System in Endodontic Treatment

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

Computer-Based Balance Training for People With Parkinson's Disease

Harnessing Online Peer Education Opioid Study

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Escoge Salud (Choose Health): a Chronic Pain Self-Management Program in Middle to Older Age Hispanic Americans